Hematology/Oncology Specialist - Orlando, FL

The Hematology-Oncology Specialist maintains strong professional relationships in the patient care continuum and represents the integrity of Karyopharm Therapeutics by providing approved disease and product information and resources to key decision makers and stakeholders within the oncology community practice setting.

RESPONSIBILITIES:

• Develop business plans, market analysis, and strategy that link to strong business results and execute accordingly
• Position on-label benefits for appropriate patients to key customer stakeholders to achieve or exceed forecasted sales goals
• Resolve issues at account level to ensure access to therapy
• Coordinate with colleagues in cross-functional areas including Market Access, Clinical Education, and Medical Affairs to facilitate customer and patient access to Karyopharm product(s) and information
• Provide customer feedback to internal stakeholders, sharing best practices, unmet needs, and business opportunities
• Assist Marketing function in identifying and inviting appropriate healthcare professionals (HCPs) to promotional and educational events or programs
• Develop and maintain mastery of clinical and technical knowledge related to product(s) promoted, the oncology marketplace, and disease management
• Foster and develop relationships with Key Opinion Leaders (KOLs), decision makers, influencers, and key stakeholders within the oncology community
• Deliver clinical and technical value at medical meetings by staffing promotional booths, as requested
• Comply with all laws and regulations and adhere to company compliance guidelines, policy and procedures
• Acts with a sense of urgency on behalf of patients and customers

• Bachelor’s degree, required
• 5+ years of pharmaceutical sales experience, with a documented history of success
• 2+ years’ oncology or rare disease pharmaceutical sales experience, including product launch(es)
• Experience in Hematology and/or Multiple Myeloma preferred
• Existing relationships with oncology practices in territory, preferred
• Strong business acumen
• Must reside in close proximity to the geography or be willing to relocate to it
• Valid driver's license and the ability to travel as necessary

At Karyopharm, base pay is one part of a competitive total rewards package that includes comprehensive benefits (medical, dental, vision, 401(k), and more), equity and the potential to receive annual target bonuses. Actual pay is based on factors such as location, experience, skills, education, and internal equity. We maintain broad salary ranges to reflect market conditions and the specialized nature of our work. The anticipated base salary range for this position is $170 K - $210 K USD.

This is a uniquely exciting time to join Karyopharm Therapeutics where we are pioneering the science of nuclear export inhibition to develop differentiated therapies for patients with cancer. We are building upon an established commercial foundation in multiple myeloma while advancing the potential of selinexor across additional hematologic and solid tumor cancers including myelofibrosis and TP53 wild-type endometrial cancer, areas where patients continue to face significant unmet needs. 

Our lead therapy, XPOVIO® (selinexor), is a first-in-class inhibitor of exportin 1 (XPO1) and is approved in the U.S. for adults with relapsed or refractory multiple myeloma, with approvals in more than 50 countries and territories outside the U.S. We are also exploring opportunities to evaluate XPO1 inhibition across myeloproliferative neoplasms and TP53 wild-type driven solid tumors using next-generation compounds, including eltanexor.  

As we prepare for our next phase of growth, we are continuing to invest in critical capabilities across the organization to support future opportunities and deepen our impact in oncology. We are looking for talented people who are motivated by meaningful work, energized by growth and momentum, and excited by the opportunity to help shape what comes next in a collaborative, fast-moving environment where individual contributions are visible and valued. 

Learn more at Karyopharm Therapeutics.